You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金域医学:获先进制造产业投资基金二期定增8.5亿元,股价一度大涨7%
格隆汇 04-16 11:51

4月15日晚间金域医学(603882.SH)披露2020年度非公开发行预案显示,拟募集资金总额不超10亿元,扣除发行费用后将用于偿还银行贷款和补充流动资金。

image.png

来源:金域医学2020年非公开发行预案

其中,拟非公开发行的股票数量合计不超过2073.4万股(含2,073.40万股),发行数量不超过此次非公开发行前公司总股本的30%非公开发行股票每股48.23元

同时,本次发行对象主要2名特定对象,包括外部战略投资者国投招商管理的先进制造产业投资基金二期及公司控股股东暨实际控制人梁耀铭。其中,先进制造产业投资基金二期认购1762.39万股,为8.5亿元梁耀铭认购311.01万股,为1.5亿元。

image.png来源:金域医学 2020年非公开发行预案

据资料显示,先进制造产业投资基金二期是2019年11月有成立,募集规模500亿元。该基金重点投向轨道交通装备、工业机器人、新能源汽车等领域,支持了宁德时代、上海联影、中集来福士等一批先进制造业企业。

受此次募集资金影响,金域医学今日开盘虽小幅下跌,但在临近10点时一度拉升后震荡回落,临近午间收盘小幅拉升。截至午间收盘,股价上升5.06%,报收69.34元,成交额4.52亿元,换手率2.38%,总市值317.5亿元。

image.png

来源:Wind

据金域医学的财报显示,公司2016年、2017年、2018年及2019年1-9月的营业收入分别为32.22亿元、37.92亿元、45.25亿元和39.20亿元,分别同比增长34.83%、17.70%、19.35%和18.17%。

image.png

金域医学2019年第三季度报告 来源:Wind

受行业当前发展趋势和竞争格局的影响,公司近年来不断扩大的业务规模,未来几年公司生产经营、市场开拓、研发投入等活动中需要大量的营运资金

值得关注的是,目前公司应收账款16.82亿元存货1.85亿元,合计占流动资产总值的66%,对公司日常的运营资金需求形成了一定压力。通过这次发行募集资金可在一定程度上解决公司因业务规模扩张而产生的营运资金需求,缓解快速发展的资金压力。

image.png

来源:Wind

此外,据公司财报显示,金域医学的资产负债率也是相当高的。其中,2016-2018年的资产负债率分别是57.51%,47.48%,50.58%,2019年截至9月的资产负债率49.04%。同时,该公司2016-2019年的流动比率和速动比率均在1以上。

image.png

来源:金域医学2020年非公开发行预案

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account